Sign up for our daily briefing

Make your busy days simpler with Axios AM/PM. Catch up on what's new and why it matters in just 5 minutes.

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Catch up on the day's biggest business stories

Subscribe to Axios Closer for insights into the day’s business news and trends and why they matter

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Stay on top of the latest market trends

Subscribe to Axios Markets for the latest market trends and economic insights. Sign up for free.

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Sports news worthy of your time

Binge on the stats and stories that drive the sports world with Axios Sports. Sign up for free.

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Tech news worthy of your time

Get our smart take on technology from the Valley and D.C. with Axios Login. Sign up for free.

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Get the inside stories

Get an insider's guide to the new White House with Axios Sneak Peek. Sign up for free.

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Catch up on coronavirus stories and special reports, curated by Mike Allen everyday

Catch up on coronavirus stories and special reports, curated by Mike Allen everyday

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Want a daily digest of the top Denver news?

Get a daily digest of the most important stories affecting your hometown with Axios Denver

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Want a daily digest of the top Des Moines news?

Get a daily digest of the most important stories affecting your hometown with Axios Des Moines

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Want a daily digest of the top Twin Cities news?

Get a daily digest of the most important stories affecting your hometown with Axios Twin Cities

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Want a daily digest of the top Tampa Bay news?

Get a daily digest of the most important stories affecting your hometown with Axios Tampa Bay

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Want a daily digest of the top Charlotte news?

Get a daily digest of the most important stories affecting your hometown with Axios Charlotte

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Want a daily digest of the top Nashville news?

Get a daily digest of the most important stories affecting your hometown with the Axios Nashville newsletter.

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Want a daily digest of the top Columbus news?

Get a daily digest of the most important stories affecting your hometown with the Axios Columbus newsletter.

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Want a daily digest of the top Dallas news?

Get a daily digest of the most important stories affecting your hometown with the Axios Dallas newsletter.

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Sign up for Axios NW Arkansas

Stay up-to-date on the most important and interesting stories affecting NW Arkansas, authored by local reporters

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

The FDA yesterday granted full approval to the Pfizer-BioNTech COVID vaccine. Will it convince more people to get vaccinated? The answer to that question will be especially important in states with low vaccination rates and surging hospitalizations, like Alabama. That state is currently one of the hardest hit by COVID in the nation.

  • Plus, FDA approval of the Pfizer vaccine raises questions about young kids.
  • And, dire conditions in Qatar for evacuees from Afghanistan.

Guests: Alabama State Health Officer Dr. Scott Harris, Axios' Tina Reed and Jonathan Swan.

Credits: Axios Today is produced in partnership with Pushkin Industries. The team includes Niala Boodhoo, Sara Kehaulani Goo, Dan Bobkoff, Alexandra Botti, Nuria Marquez Martinez, Sabeena Singhani, and Ben O'Brien. Music is composed by Evan Viola. You can reach us at podcasts@axios.com. You can text questions, comments and story ideas to Niala as a text or voice memo to 202-918-4893.

Go deeper:

Transcript

MARGARET TALEV: Good morning! Welcome to Axios Today! It’s Tuesday, August 24th. I’m Margaret Talev, in for Niala Boodhoo. Here’s what we’re watching today: dire conditions in Qatar for evacuees from Afghanistan. Plus: FDA approval of the Pfizer vaccine raises questions about young kids. But first, today’s One Big Thing: what that FDA approval means for vaccination rates in a hard-hit state.

The FDA yesterday granted full approval to the Pfizer BioNTech COVID vaccine. Will it convince more people to get vaccinated though? The answer to that question will be especially important in states with low vaccination rates and surging hospitalizations, like Alabama, that state is currently one of the hardest hit by COVID in the nation. Dr. Scott Harris is the state health officer for the department of public health in Alabama, Dr. Harris, good morning.

DR. SCOTT HARRIS: Good morning.

MARGARET: We last spoke with you in December, just before the public really started getting the vaccine and it's been eight months now. What's the current situation in hospitals in Alabama?

DR. HARRIS: Alabama has really encountered a difficult time, particularly over the last three to four weeks. We've seen our hospital numbers increase at a really rapid rate. We're not quite at the peak that we established back in January in terms of total Covid hospitalizations, but we've especially had problems with our ICU capacity. We have many, many more people needing critical care than we have beds.

MARGARET: The stats — 2,588 Covid cases in the last day or so, 38 of those are pediatric cases.

DR. HARRIS: Yeah, we really, we have seen an increase in pediatric cases that we had not identified before. Total pediatric hospitalizations make up, you know, between one and two percent of all hospitalizations, but that's a lot for kids. Kids don't usually end up in the hospital at that rate with most illnesses.

MARGARET: So big news now, full FDA authorization for the Pfizer vaccine. About a little more than a third of the folks in Alabama are fully vaccinated. That's a huge rate of unvaccinated people. Could that full FDA authorization help actually increase the vaccination rates in your state?

DR. HARRIS: It is a very big deal. It will certainly help with some people's concerns. A lot of people have used that as maybe an excuse to not get vaccinated. Now they don't have that excuse. I hope they don't find a new excuse. We definitely have a lot of vaccine hesitancy and there are a lot of different reasons for that, but I do believe we've got some people who are still just on the fence, that so-called movable middle, that we're hoping to get to now.

MARGARET: Doctor, when we last spoke back in December, we had talked about the concerns of Black Americans, Black residents of Alabama around the vaccine, the historical reasons for that tied to systemic racism, experimentation, Tuskegee. It turned out that the vaccine hesitancy didn't just impact Black Americans, right?

DR. HARRIS: Well, that's exactly right. We actually anticipated what we thought we might see in our African American community. We had a really good plan for that. We worked well on that. And in fact, some of our predominantly African American counties are the most vaccinated counties in our state. We're vaccinating Black Alabamians at a rate a little higher than white Alabamians. It's rural white communities where we really encountered a lot of resistance.

MARGARET: Donald Trump himself was actually booed at a rally in Alabama, right, within the last few days for recommending the vaccine. Are there any lessons that you have learned from the outreach with people who are vaccine hesitant? What have you learned about the approach and how it needs to change?

DR. HARRIS: Yeah, I think you wouldn’t be surprised to hear me say that it really comes down to trust. You know, we kind of naively thought if we just rolled out the science, then people would be compelled to accept it because everybody believes in science. But in fact, we have people that just aren't really interested in hearing a message from state government in general or public health in particular. We really have found that they want to listen to people that they trust. And so that's really been the crux of what we've been trying to do with our communications campaign. We want people to talk to their own doctor. Their own healthcare provider, people in their communities that they believe provide them with good information and you know, it's hard to do that. It's sort of one conversation at a time. It's really labor intensive. It takes a lot of work to do that and you know, sometimes it works and sometimes it doesn't work.

MARGARET: Dr. Scott Harris is the state health officer for the department of public health in Alabama, and has got a heck of a job. Thank you for all your work and we hope to talk to you again soon.

DR. HARRIS: Thank you very much.

MARGARET: In 15 seconds: the Pfizer FDA approval invites new questions about young kids.

[AD]

MARGARET: Welcome back to Axios Today. I'm Margaret Talev, in this week for Niala Boodhoo.

After the FDA granted full approval for Pfizer's COVID vaccine for those 16 and older, Axios healthcare editor Tina Reed tells us that one of the immediate questions for many was what that might mean for younger kids — those under 12 who are not yet able to get any of the COVID vaccines.

TINA REED: Multiple doctors I spoke with said they expected that parents would be pushing for what's known as off-label use by pediatricians to administer the vaccines to these kids. Off-label use is common more broadly among drugs that have been approved by the FDA. And it means that the drug that is being used is being used for something other than what, for what it was originally approved for, or for a different group than what it was originally approved for. Acting FDA commissioner, Janet Woodcock was quick to warn on Monday that children are not little adults and that more data was needed. The American Academy of Pediatrics similarly warned pediatricians against off-label use. The final word actually appeared to come from the CDC on Monday when they said off-label use in kids under 12 was not authorized, saying the administration of it might not be covered under the PREP Act and that providers might not have immunity from claims. So for now, kids 11 and under will have to continue to wait until more data comes in.

MARGARET: Axios healthcare editor, Tina Reed.

MARGARET: The Biden administration is holding thousands of evacuees from Afghanistan at an air base in Doha, Qatar, where they're being vetted as potential refugees before they can be brought to the U.S. or another country. And according to emails shared exclusively with Axios, the conditions there are quote “a living hell.” We're here with Axios’ national political correspondent, Jonathan Swan, with more on this story. Hi, Jonathan.

JONATHAN SWAN: Hey Margaret.

MARGARET: Jonathan, tell us: What are things like at the Doha air base? And how do we know this?

JONATHAN: So, shortly before eight o'clock last Friday morning, an official at U.S. Central Command sends this email to some of his colleagues at Central Command, and also some officials at the U.S. State department. Quote, “while not in any way downplaying the conditions in Kabul or the conditions the Afghanis [sic] are escaping from, the current conditions in Doha are of our own doing.” He described it as quote “a life-threatening humanitarian disaster.” He then goes on to quote staff communications about the conditions at the Doha air base quote “a humid day today, where the Afghans are housed is a living hell. Trash, urine, fecal matter, spilled liquids and vomit cover the floors.”

MARGARET: Reading these descriptions, does it seem that the U.S. was actually prepared to house these evacuees?

JONATHAN: No. Uh, I've spoken to sources inside the U.S. government who are literally working on this right now. And ... I can't convey to you the anguish and the anger, frankly, about the lack of foresight that things could fall apart so quickly and that they would need to have these facilities up and running so quickly.

MARGARET: Do we have a sense of whether the Biden administration Is improving, whether these conditions are getting better?

JONATHAN: The-the press officers are saying that they've mobilized to try and improve the conditions at the Doha air base. Make it more sanitary, to make sure that there isn't, what this person warned about, a humanitarian crisis.

MARGARET: Axios' National Political Correspondent Jonathan Swan. Thanks for being with us, Jonathan.

JONATHAN: Thanks for having me.

MARGARET: A few hours after we spoke with Jonathan, the Pentagon told Axios that they are taking steps to improve conditions on the ground including adding more toilets and offering traditional Afghan meals three times a day. The State Department also responded to say quote “we are working quickly to alleviate bottlenecks and are surging consular personnel in Qatar.”

One last thing before we go: the Paralympics kick off today in Tokyo ... with 234 athletes representing the US across eight sports. A record number of 29 publicly-out LGBTQ athletes are also set to compete in this year’s games. You can catch the first event — the women’s 400 meter freestyle — starting at 8 p.m. Eastern tonight.

That’s all we’ve got for you today! I’m Margaret Talev — thanks for listening — stay safe and we’ll see you back here tomorrow morning.

Go deeper

Oct 18, 2021 - Axios Twin Cities

Minnesota offers cash and chance at $100K scholarship as vaccine incentive for teens

Expand chart
Data: Minnesota COVID-19 Response; Chart: Will Chase/Axios

Minnesota is offering new incentives to shot-wary teens in an effort to boost the state's COVID-19 vaccination rates.

Driving the news: 12 to 17 year olds who get both doses over the next six weeks will receive a $200 Visa gift card, Gov. Tim Walz's administration announced Monday.

  • Kids vaccinated during this period can also enter a lottery for one of five $100,000 scholarships to attend any of the state's public or private colleges or universities.

Why it matters: Public health officials say increasing vaccination rates among young Minnesotans is key to curbing spread of the virus, especially in schools.

Oct 19, 2021 - Health

J&J expects $2.5 billion of vaccine sales this year

J&J's COVID-19 vaccine. Photo: Paul Hennessy/SOPA Images/LightRocket via Getty Images

Johnson & Johnson registered $502 million of global revenue from its COVID-19 vaccine in the third quarter, bringing year-to-date vaccine sales to $766 million.

The big picture: J&J, which is selling the vaccine at a not-for-profit price of $7.50 per dose, still expects to generate $2.5 billion of COVID vaccine sales this year, executives said Tuesday. But that total will still dwarf the use and sales of the vaccines made by Pfizer/BioNTech and Moderna.

52 mins ago - Technology

Facebook is a news media magnet

Expand chart
Data: Signal AI; Chart: Jared Whalen/Axios

New data finds that Facebook has been mentioned in more online stories in the U.S. in the past year than all of its major tech competitors combined.

Why it matters: Press scrutiny of Facebook has become so intense and negative that the tech giant is reportedly planning to rename itself as soon as next week to signal that it's more than just a social media company.